Suchergebnisse - (Subject:"Adalimumab")

PubPharm (2.310)

1

Anti-tumor necrosis factor (aTNF) weaning strategy in juvenile idiopathic arthritis (JIA) : does duration matter?

enthalten in: Clinical rheumatology | 2024

von Teh, K. | Das, L. | Book, Y. | +3

2

Influence of Gender on the Persistence of Different Tumor Necrosis Factor Inhibitor Treatments in Patients With Psoriatic Arthritis

enthalten in: The Journal of rheumatology | 2024

von García-Porrúa, C. | Iñiguez-Ubiaga, C. | Pinto-Tasende, J.

3

Molecular Profiling of Axial Spondyloarthritis Patients Reveals an Association between Innate and Adaptive Cell Populations and Therapeutic Response to Tumor Necrosis Factor Inhibitors

enthalten in: Biomolecules | 2024

von Sobral, D. | Fernandes, A. | Bernardes, M. | +15

4

Adalimumab-induced central nervous system demyelination in a patient with rheumatoid arthritis

enthalten in: The neuroradiology journal | 2024

von Shirah, B. | Altwirgi, S. | Faridoon, I. | +1

5

Efficacy, retention rate and safety of adalimumab treatment in patients with non-infectious uveitis and scleritis : a real-world, retrospective, single-centre study

enthalten in: Eye (London, England) | 2024

von Çam, F. | Celiker, H.

6

Impact of filgotinib on pain control in the phase 3 FINCH studies

enthalten in: RMD open | 2024

von Taylor, P. | Kavanaugh, A. | Nash, P. | +10

ErratumIn: RMD Open. 2024 Apr 4;10(2):. - PMID 38580354

7

Forty-Eight-Month Monitoring of Disease Activity in Patients with Long-Standing Rheumatoid Arthritis Treated with TNF-α Inhibitors : Time for Clinical Outcome Prediction and Biosimilar vs Biologic Originator Performance

enthalten in: Clinical drug investigation | 2024

von Colina, M. | Khodeir, M. | Rimondini, R. | +4

8

Formation and clearance of TNF-TNF inhibitor complexes during TNF inhibitor treatment

enthalten in: British journal of pharmacology | 2024

von Berkhout, L. | I'Ami, M. | Kruithof, S. | +11

9

Patient self-reported experience and satisfaction with golimumab and etanercept treatments for rheumatic diseases : A cohort study

enthalten in: Medicine | 2024

von Xia, W. | Zhou, L. | Gao, W. | +9

10

Comparison of the efficacy and safety of tocilizumab, sarilumab, and olokizumab in patients with active rheumatoid arthritis : a network meta-analysis of randomized controlled trials

enthalten in: Zeitschrift fur Rheumatologie | 2024

von Ho Lee, Y. | Gyu Song, G.

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[231]